Human Milk Oligosaccharides (HMO) Market Size, Share & Trends Analysis Report By Application (Food Supplements, Functional Food & Beverages, Infant Formula), By Region, And Segment Forecasts, 2018 - 2025

Published: Dec, 2018 | Pages: 91 | Publisher: Grand View Research
Industry: Food & Beverages | Report Format: Electronic (PDF)

The global human milk oligosaccharides (HMO) market size is expected to reach USD 71.2 billion by 2025, according to a new report by Grand View Research, Inc. The HMO market is projected to witness a strong CAGR of 21.9% during the forecast period. Growing consumer awareness regarding infant health is expected to be the key factor driving the market. Moreover, heavy investments by prominent companies in emerging economies is anticipated to fuel the industry growth. The global infant formula market was valued at over USD 45.0 billion in 2016, with Asia being the dominant region.

Increasing number of middle-class households and number of working women are among the key reasons behind the growth of the infant formula market. Presence of numerous companies and resultant competition in this sector is likely to facilitate the usage of HMO in infant formula over the forecast period, boosting the market growth. High demand for dietary supplements owing to increased health consciousness is also expected to augment the market growth over the forecast period. HMOs in dietary supplements provide benefits, such as enhanced immune system and digestive comfort.

For example, DuPont Nutrition & Health's CARE4U is used as a dietary supplement ingredient. The market witnessing intense competition due to the increasing number of market entrants. For instance, in June 2018, BASF announced that it will launch its HMO ingredient 2'FL by early 2019. Similarly, in June 2018, Abbott introduced its new infant formula product, Similac Eye-Q Plus with HMO, in Vietnam.

Further key findings from the study suggest:

• In terms of revenue, the infant formula segment is expected to witness the fastest CAGR of 22.0% over the forecast period

• North America accounted for a share of over 80% in 2017, in terms of revenue on account of early adoption of the product and presence of numerous infant formula companies in the region

• Business expansion and product launch are the major strategies undertaken by major companies in the global HMO market.

• For instance, in November 2016, Inbiose NV partnered with DuPont Nutrition & Health and launched a new infant nutrition ingredient, based on complex carbohydrates found in human milk.

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Research Methodology
                 1.2 Research Scope & Assumptions
                 1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 HMO Industry Outlook
                 3.1 HMO market segmentation
                 3.2 HMO market size and growth prospects, 2014 - 2025
                 3.3 HMO - Value chain analysis
                     3.3.1 Vendor landscape
                 3.4 Raw material outlook
                 3.5 Technology overview
                 3.6 Regulatory framework
                     3.6.1 European Commission: Regulation (EC) No 258/97 of the European Parliament
                 3.7 HMO market dynamics
                     3.7.1 Market driver analysis
                         3.7.1.1 Positive dairy industry outlook
                         3.7.1.2 Growing dietary supplements market
                         3.7.1.3 Rising concerns towards gut health
                     3.7.2 Market restraints analysis
                         3.7.2.1 High production and R&D cost
                 3.8 Key opportunities prioritized
                 3.9 HMO competitive landscape
                     3.9.1 Strategy Framework
                 3.10 HMO market: Porter's analysis
                 3.11 HMO market PESTEL analysis
Chapter 4 HMO Product Outlook
                 4.1 2'-Fucosyllactose (2'FL)
                     4.1.1 Specifications
                     4.1.2 Key Suppliers
                     4.1.3 Applications
                     4.1.4 Patents
                     4.1.5 Production Routes
                     4.1.6 Manufacturers
                 4.2 3'-Fucosyllactose (3'FL)
                     4.2.1 Specifications
                     4.2.2 Key Suppliers
                     4.2.3 Applications
                     4.2.4 Patents
                     4.2.5 Production Routes
                     4.2.6 Manufacturers
                 4.3 3'-Sialyllactose (3'SL)
                     4.3.1 Specifications
                     4.3.2 Key Suppliers
                     4.3.3 Application
                     4.3.4 Patents
                     4.3.5 Production Routes
                     4.3.6 Manufacturers
                 4.4 6'-Sialyllactose (6'SL)
                     4.4.1 Specifications
                     4.4.2 Key Suppliers
                     4.4.3 Applications
                     4.4.4 Patents
                     4.4.5 Production Routes
                     4.4.6 Manufacturers
                 4.5 Lacto-N-tetraose (LNT)
                     4.5.1 Specifications
                     4.5.2 Key Suppliers
                     4.5.3 Patents
                     4.5.4 Applications
                     4.5.5 Production Routes
                     4.5.6 Manufacturers
                 4.6 Lacto-N-neotetraose (LNnT)
                     4.6.1 Specifications
                     4.6.2 Key Suppliers
                     4.6.3 Patents
                     4.6.4 Applications
                     4.6.5 Production Routes
                     4.6.6 Manufacturers
Chapter 5 HMO Application Outlook
                 5.1 Global HMO market volume share, by application, 2017 & 2025
                 5.2 Infant Formula
                     5.2.1 Market estimates and forecast in infant formula, 2014 - 2025 (Tons) (USD 000)
                     5.2.2 Market estimates and forecast in infant formula, by region, 2014 - 2025 (Tons) (USD 000)
                 5.3 Functional Food & Beverages
                     5.3.1 Market estimates and forecast in functional food & beverages, 2014 - 2025 (Tons) (USD 000)
                     5.3.2 Market estimates and forecast in functional food & beverages, by region, 2014 - 2025 (Tons) (USD 000)
                 5.4 Food Supplements
                     5.4.1 Market estimates and forecast in food supplements, 2014 - 2025 (Tons) (USD 000)
                     5.4.2 Market estimates and forecast in food supplements, by region, 2014 - 2025 (Tons) (USD 000)
                 5.5 Others
                     5.5.1 Market estimates and forecast in other applications, 2014 - 2025 (Tons) (USD 000)
                     5.5.2 Market estimates and forecast in other applications, by region, 2014 - 2025 (Tons) (USD 000)
Chapter 6 HMO Regional Outlook
                 6.1 Global HMO market volume share by region, 2017 & 2025
                 6.2 North America
                     6.2.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                     6.2.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.2.3 U.S.
                         6.2.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.2.3.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                 6.3 Europe
                     6.3.1 Market estimates and forecasts, 2012-2020, (Tons) (USD 000)
                     6.3.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.3.3 U.K.
                         6.3.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.3.3.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.3.4 Germany
                         6.3.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.3.4.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                 6.4 Asia Pacific
                     6.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                     6.4.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.4.3 China
                         6.4.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.4.3.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.4.4 Japan
                         6.4.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.4.4.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                 6.5 Latin America
                     6.5.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                     6.5.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                     6.5.3 Brazil
                         6.5.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                         6.5.3.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
                 6.6 MEA
                     6.6.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
                     6.6.2 Market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD 000)
Chapter 7 Competitive Landscape
                 7.1 Inbiose NV
                     7.1.1 Company Overview
                     7.1.2 Financial Performance
                     7.1.3 Product Benchmarking
                     7.1.4 Strategic Initiatives
                 7.2 Elicityl S.A.
                     7.2.1 Company Overview
                     7.2.2 Financial Performance
                     7.2.3 Product Benchmarking
                     7.2.4 Strategic Initiatives
                 7.3 Jennewein Biotechnologie GmbH
                     7.3.1 Company Overview
                     7.3.2 Financial Performance
                     7.3.3 Product Benchmarking
                     7.3.4 Strategic Initiatives
                 7.4 Glycom A/S
                     7.4.1 Company Overview
                     7.4.2 Financial Performance
                     7.4.3 Product Benchmarking
                     7.4.4 Strategic initiatives
                 7.5 Medolac Laboratories
                     7.5.1 Company Overview
                     7.5.2 Financial Performance
                     7.5.3 Product Benchmarking
                     7.5.4 Strategic Initiatives
                 7.6 ZuChem Inc.
                     7.6.1 Company Overview
                     7.6.2 Financial Performance
                     7.6.3 Product Benchmarking
                     7.6.4 Strategic Initiatives
                 7.7 Glycosyn LLC
                     7.7.1 Company Overview
                     7.7.2 Financial Performance
                     7.7.3 Product Benchmarking
                     7.7.4 Strategic initiatives

List of Tables

TABLE 1 HMO - Industry Summary & Key Buying Criteria
TABLE 2 Global HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
TABLE 3 Global HMO market volume, by region, 2014 - 2025 (Tons)
TABLE 4 Global HMO market revenue, by region, 2014 - 2025 (USD 000)
TABLE 5 Global HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 6 Global HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 7 Vendor landscape
TABLE 8 HMO - Key market driver analysis
TABLE 9 HMO - Key market restraint analysis
TABLE 10 2'FL Specifications
TABLE 11 3'FL Specifications
TABLE 12 3'SL Specifications
TABLE 13 6'SL Specifications
TABLE 14 LNT Specifications
TABLE 15 LNnT Specifications
TABLE 16 Global HMO market estimates and forecasts in infant formula, 2014 - 2025 (Tons) (USD 000)
TABLE 17 Global HMO market estimates and forecast in infant formula, by region, 2014 - 2025 (Tons)
TABLE 18 Global HMO market estimates and forecast in infant formula, by region, 2014 - 2025 (USD 000)
TABLE 19 Global HMO market estimates and forecast in functional food & beverages, 2014 - 2025 (Tons) (USD 000)
TABLE 20 Global HMO market estimates and forecast in functional food & beverages, by region, 2014 - 2025 (Tons)
TABLE 21 Global HMO market estimates and forecast in functional food & beverages, by region, 2014 - 2025 (USD 000)
TABLE 22 Global HMO market estimates and forecast in food supplements, 2014 - 2025 (Tons) (USD 000)
TABLE 23 Global HMO market estimates and forecast in food supplements, by region, 2014 - 2025 (Tons)
TABLE 24 Global HMO market estimates and forecast in food supplements, by region, 2014 - 2025 (USD 000)
TABLE 25 Global HMO market estimates and forecast in other applications, 2014 - 2025 (Tons) (USD 000)
TABLE 26 Global HMO market volume in other applications, by region, 2014 - 2025 (Tons)
TABLE 27 Global HMO market revenue in other applications, by region, 2014 - 2025 (USD 000)
TABLE 28 North America HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 29 North America HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 30 North America HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 31 U.S. HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 32 U.S. HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 33 U.S. HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 34 Europe HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 35 Europe HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 36 Europe HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 37 U.K. HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 38 U.K. HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 39 U.K. HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 40 Germany HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
TABLE 41 Germany HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 42 Germany HMO market revenue, by application, 2014 - 2025 (USD 000)
TABLE 43 Asia Pacific HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 44 Asia Pacific HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 45 Asia Pacific HMO market revenue, by application 2014 - 2025 (USD 000)
TABLE 46 China HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 47 China HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 48 China HMO market revenue, by application 2014 - 2025 (USD 000)
TABLE 49 Japan HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 50 Japan HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 51 Japan HMO market revenue, by application 2014 - 2025 (USD 000)
TABLE 52 Latin America HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 53 Latin America HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 54 Latin America HMO market revenue, by application, 2014 - 2025 (USD Thousand)
TABLE 55 Brazil HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD 000)
TABLE 56 Brazil HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 57 Brazil HMO market revenue, by application 2014 - 2025 (USD 000)
TABLE 58 MEA HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
TABLE 59 MEA HMO market volume, by application, 2014 - 2025 (Tons)
TABLE 60 MEA HMO market revenue, by application 2014 - 2025 (USD 000)

List of Figures

FIG. 1 HMO market segmentation
FIG. 2 Global HMO market volume and revenue, 2014 - 2025 (Tons) (USD 000)
FIG. 3 HMO market - Value chain analysis
FIG. 4 HMO: Raw material outlook
FIG. 5 HMO market dynamics
FIG. 6 Global trade in dairy products, 2016 and 2017 (Thousand Tons)
FIG. 7 Global Dietary Supplements Market, 2016 - 2024 (USD Million)
FIG. 8 HMO - Key opportunities prioritized
FIG. 9 Strategy framework
FIG. 10 HMO market: Porter's analysis
FIG. 11 HMO market PESTEL analysis
FIG. 12 Global HMO market volume share, by application, 2017 & 2025
FIG. 13 Global HMO market volume share by region, 2017 & 2025